Markets
Arcutis Biotherapeutics Director Welgus Sells $114K in Shares: What the Insider Move Signals
A director at Arcutis Biotherapeutics has sold approximately $114,000 worth of company stock, drawing attention from traders who track insider activity as a sentiment signal. Here is what the transaction reveals about the stock's near-term risk profile.